health
Health & Medicine
The FDA has approved a new drug that could extend survival for late-stage pancreatic cancer patients, offering potential hope for a disease with historically poor outcomes.
HIGH confiança
Cobertura (205 artigos)
Ainda não há cobertura reunida para este tópico.